Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data

Background: Sarcomatoid differentiation/histology of renal cell carcinoma (sRCC) in patients with metastatic renal cell carcinoma (mRCC) is still underresearched in current therapy regimes. We aimed to evaluate the impact of sRCC on outcomes in patients with mRCC treated with tyrosine kinase inhibit...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Florian Janisch, Christina Kienapfel, Constantin Fühner, Thomas Klotzbücher, Phillip Marks, Tobias Hillemacher, Christian P. Meyer, Takehiro Iwata, Mehdi Kardoust Parizi, Guido Sauter, Margit Fisch, Shahrokh F. Shariat, Roland Dahlem, Michael Rink
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2021-11-01
Schriftenreihe:	Frontiers in Surgery
Schlagworte:	renal cell carcinoma tyrosine kinase inhibitors targeted therapy sarcomatoid histology therapy regime
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fsurg.2021.763271/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!